Over-expression of another RBP RBM10 induces p53-dependent apoptosis in various cancer cells (Jung et al., 2020), indicating that CELF6 is likely to contribute to tumorigenesis via regulating the AS of TP53 or CD44 in non-small cell lung cancer cells. Here, RBM10 is linked to non-small cell lung carcinoma.